subject with confirm diagnosis of human immunodeficiency virus hiv infection be exclude at the investigator 's discretion if he/she feel that 1 a potential drug interaction between zd6474 vandetanib and any of the patient 's anti-hiv medication could influence the efficacy of the anti-hiv medication or 2 it may place the patient at risk due to the pharmacologic activity of zd6474 vandetanib 